Spyridon Papapetropoulos - Net Worth and Insider Trading

Spyridon Papapetropoulos Net Worth

The estimated net worth of Spyridon Papapetropoulos is at least $280,296 dollars as of 2024-05-17. Spyridon Papapetropoulos is the Director of Lipocine Inc and owns about 21,739 shares of Lipocine Inc (LPCN) stock worth over $134,782. Spyridon Papapetropoulos is the Director of Adamas Pharmaceuticals Inc and owns about 15,975 shares of Adamas Pharmaceuticals Inc (ADMS) stock worth over $131,315. Spyridon Papapetropoulos is also the Chief Medical Officer of Vigil Neuroscience Inc and owns about 4,000 shares of Vigil Neuroscience Inc (VIGL) stock worth over $14,200. Details can be seen in Spyridon Papapetropoulos's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Spyridon Papapetropoulos has not made any transactions after 2022-11-22 and currently still holds the listed stock(s).

Transaction Summary of Spyridon Papapetropoulos

To

Spyridon Papapetropoulos Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Spyridon Papapetropoulos owns 2 companies in total, including Lipocine Inc (LPCN) , and Vigil Neuroscience Inc (VIGL) .

Click here to see the complete history of Spyridon Papapetropoulos’s form 4 insider trades.

Insider Ownership Summary of Spyridon Papapetropoulos

Ticker Comapny Transaction Date Type of Owner
LPCN Lipocine Inc 2022-11-22 director
VIGL Vigil Neuroscience Inc 2022-11-18 Chief Medical Officer

Spyridon Papapetropoulos Latest Holdings Summary

Spyridon Papapetropoulos currently owns a total of 3 stocks. Among these stocks, Spyridon Papapetropoulos owns 21,739 shares of Lipocine Inc (LPCN) as of November 22, 2022, with a value of $134,782 and a weighting of 48.09%. Spyridon Papapetropoulos owns 15,975 shares of Adamas Pharmaceuticals Inc (ADMS) as of March 11, 2021, with a value of $131,315 and a weighting of 46.85%. Spyridon Papapetropoulos also owns 4,000 shares of Vigil Neuroscience Inc (VIGL) as of November 18, 2022, with a value of $14,200 and a weighting of 5.07%.

Latest Holdings of Spyridon Papapetropoulos

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LPCN Lipocine Inc 2022-11-22 21,739 6.20 134,782
ADMS Adamas Pharmaceuticals Inc 2021-03-11 15,975 8.22 131,315
VIGL Vigil Neuroscience Inc 2022-11-18 4,000 3.55 14,200

Holding Weightings of Spyridon Papapetropoulos


Spyridon Papapetropoulos Form 4 Trading Tracker

According to the SEC Form 4 filings, Spyridon Papapetropoulos has made a total of 1 transactions in Lipocine Inc (LPCN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Lipocine Inc is the acquisition of 21,739 shares on November 22, 2022, which cost Spyridon Papapetropoulos around $10,217.

According to the SEC Form 4 filings, Spyridon Papapetropoulos has made a total of 1 transactions in Adamas Pharmaceuticals Inc (ADMS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Adamas Pharmaceuticals Inc is the acquisition of 5,975 shares on March 11, 2021, which cost Spyridon Papapetropoulos around $30,234.

According to the SEC Form 4 filings, Spyridon Papapetropoulos has made a total of 2 transactions in Vigil Neuroscience Inc (VIGL) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Vigil Neuroscience Inc is the sale of 300 shares on November 18, 2022, which brought Spyridon Papapetropoulos around $4,200.

Insider Trading History of Spyridon Papapetropoulos

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Spyridon Papapetropoulos Trading Performance

GuruFocus tracks the stock performance after each of Spyridon Papapetropoulos's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Spyridon Papapetropoulos is 31.13%. GuruFocus also compares Spyridon Papapetropoulos's trading performance to market benchmark return within the same time period. The performance of stocks bought by Spyridon Papapetropoulos within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Spyridon Papapetropoulos's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Spyridon Papapetropoulos

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -9.44
Relative Return to S&P 500(%) -9

Spyridon Papapetropoulos Ownership Network

Ownership Network List of Spyridon Papapetropoulos

No Data

Ownership Network Relation of Spyridon Papapetropoulos


Spyridon Papapetropoulos Owned Company Details

What does Lipocine Inc do?

Who are the key executives at Lipocine Inc?

Spyridon Papapetropoulos is the director of Lipocine Inc. Other key executives at Lipocine Inc include director & President and CEO Mahesh V. Patel , Chief Medical Officer George Nomikos , and Principal Accounting Officer Krista Fogarty .

Lipocine Inc (LPCN) Insider Trades Summary

Over the past 18 months, Spyridon Papapetropoulos made 1 insider transaction in Lipocine Inc (LPCN) with a net purchase of 21,739. Other recent insider transactions involving Lipocine Inc (LPCN) include a net purchase of 208,706 shares made by Mahesh V. Patel , a net purchase of 4,000 shares made by Richard Dana Ono ,

In summary, during the past 3 months, insiders sold 0 shares of Lipocine Inc (LPCN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lipocine Inc (LPCN) were sold and 234,445 shares were bought by its insiders, resulting in a net purchase of 234,445 shares.

Lipocine Inc (LPCN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Lipocine Inc Insider Transactions

No Available Data

Spyridon Papapetropoulos Mailing Address

Above is the net worth, insider trading, and ownership report for Spyridon Papapetropoulos. You might contact Spyridon Papapetropoulos via mailing address: C/o Adamas Pharmaceuticals, Inc., 1900 Powell St., Suite 1000, Emeryville Ca 94608.

Discussions on Spyridon Papapetropoulos

No discussions yet.